Inactive Instrument
Ceapro Inc. Stock OTC Markets
Stocks
CRPOF
CA1499071076
Biotechnology & Medical Research
OTC Markets Traded| 1 day | -13.04% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gilles Gagnon
CEO | Chief Executive Officer | 72 | 21/06/2012 |
| Director of Finance/CFO | - | - | |
Michael Teifel
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Gilles Gagnon
BRD | Director/Board Member | 72 | 01/01/2007 |
William Li
BRD | Director/Board Member | 63 | 20/11/2014 |
Ulrich Kosciessa
BRD | Director/Board Member | - | 28/04/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -13.04% | -14.36% | - | - | 12.8M | ||
| +1.02% | +4.95% | +3.67% | +25.46% | 51.21B | ||
| -0.77% | -2.29% | +491.67% | +536.84% | 45.35B | ||
| -0.57% | +7.78% | +37.59% | +18.12% | 42.84B | ||
| +2.08% | +2.86% | +23.03% | +91.37% | 42.29B | ||
| -2.27% | -5.67% | +14.55% | +50.34% | 32.15B | ||
| -1.75% | +3.36% | +30.70% | +134.83% | 17.31B | ||
| +0.20% | +1.41% | - | - | 16.55B | ||
| +1.12% | +6.35% | +11.00% | +32.62% | 14.84B | ||
| -0.35% | +6.77% | +81.65% | +48.76% | 14.25B | ||
| Average | -1.41% | +3.06% | +86.73% | +117.29% | 30.75B | |
| Weighted average by Cap. | +0.02% | +2.89% | +105.27% | +136.11% |
Employees
-
















